DB
LFST icon

Dmitry Balyasny’s Lifestance Health LFST Stock Holding History

Dmitry Balyasny’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-391,149
Closed -$2.49M – 3287
2026
Q1 		$2.49M Buy
391,149
+352,372
+909% +$2.45M ﹤0.01% 1687
2025
Q4 		$273K Buy
+38,777
New +$234K ﹤0.01% 2763
2025
Q3 		– Sell
-63,727
Closed -$329K – 3216
2025
Q2 		$329K Buy
63,727
+46,740
+275% +$280K ﹤0.01% 2449
2025
Q1 		$113K Buy
+16,987
New +$129K ﹤0.01% 2673
2023
Q2 		– Sell
-11,362
Closed -$84.4K – 2558
2023
Q1 		$84.4K Buy
+11,362
New +$63K ﹤0.01% 2335
2021
Q3 		– Sell
-125,000
Closed -$3.48M – 2204
2021
Q2 		$3.48M Buy
+125,000
New +$3.3M 0.02% 829

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Dmitry Balyasny's LFST Position: Q2 2026 in Review

Dmitry Balyasny sold out of Lifestance Health (LFST) in Q2 2026, closing a stake of 391,149 shares — an estimated $2.49M sold.

Dmitry Balyasny first reported a position in LFST in Q2 2021 and held it in 6 quarters. The position peaked at $3.48M in Q2 2021. 285 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Dmitry Balyasny reported no remaining Lifestance Health position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 391,149 Lifestance Health shares in Q2 2026, an estimated $2.49M.
  • Dmitry Balyasny first reported a position in Lifestance Health in Q2 2021 and held it in 6 quarters.
  • Dmitry Balyasny's Lifestance Health position peaked at $3.48M in Q2 2021.
  • 285 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.